SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Improving transparency to build trust in real‐world secondary data studies for hypothesis testing—Why, what, and how: recommendations and a road map from the real‐world evidence transparency initiative
7 references·1 citing·36 second hop
Improving transparency to build trust in real‐world secondary data studies for hypothesis testing—Why, what, and how: recommendations and a road map from the real‐world evidence transparency initiative (2020)Improving transparency to build trust in …Policies for Use of Real-World Data in Health Technology Assessment (HTA): A Comparative Study of Six HTA Agencies (2017)Policies for Use of Real-Worl…The GRACE Checklist: A Validated Assessment Tool for High Quality Observational Studies of Comparative Effectiveness (2016)The GRACE Checklist: A Valida…ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions (2016)ROBINS-I: a tool for assessin…Improving the Transparency of Prognosis Research: The Role of Reporting, Data Sharing, Registration, and Protocols (2014)Improving the Transparency of…Registration of observational studies: Is it time? (2010)Registration of observational…Comparative Effectiveness Research: Challenges for Medical Journals (2010)Comparative Effectiveness Res…A Checklist for Retrospective Database Studies—Report of the ISPOR Task Force on Retrospective Databases (2003)A Checklist for Retrospective…The FAIRification of research in real‐world evidence: A practical introduction to reproducible analytic workflows using Git and R (2024)The FAIRification of research…Guidelines for Reporting Health Research: The EQUATOR Network's Survey of Guideline Authors (2008)Initial National Priorities for Comparative Effectiveness Research (2009)Recommendations of the Panel on Cost-Effectiveness in Health and Medicine (1996)Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs (2000)Studying Prescription Drug Use and Outcomes With Medicaid Claims Data (2007)Propuesta de guía para la evaluación económica aplicada a las tecnologías sanitarias (2009)Clinical and biological predictors of psychedelic response in the treatment of psychiatric and addictive disorders: A systematic review (2021)Publication bias in clinical research (1991)Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration (2007)Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration (2007)Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis ( TRIPOD ): the TRIPOD statement (2015)Exploratory Research (2020)The Existence of Publication Bias and Risk Factors for Its Occurrence (1990)Cumulative Meta-Analysis of Therapeutic Trials for Myocardial Infarction (1992)Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK) (2005)Individual Participant Data (IPD) Meta-analyses of Diagnostic and Prognostic Modeling Studies: Guidance on Their Use (2015)Improving Transparency to Build Trust in Real-World Secondary Data Studies for Hypothesis Testing—Why, What, and How: Recommendations and a Road Map from the Real-World Evidence Transparency Initiative (2020)Methodology over metrics: current scientific standards are a disservice to patients and society (2021)Which clinical studies provide the best evidence? (2000)Methodological quality checklist for studies based on observational methodology (MQCOM) (2019)Real-World Evidence: Bridging Gaps in Evidence to Guide Payer Decisions (2020)The Measurement of Observer Agreement for Categorical Data (1977)The Cochrane Collaboration's tool for assessing risk of bias in randomised trials (2011)The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses (2014)RoB 2: a revised tool for assessing risk of bias in randomised trials (2019)The PRISMA 2020 statement: an updated guideline for reporting systematic reviews (2021)Two new Later Stone Age sites from the Final Pleistocene in the Falémé Valley, eastern Senegal (2024)Three Approaches to Qualitative Content Analysis (2005)Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups (2007)Using Real-World Data for Coverage and Payment Decisions: The ISPOR Real-World Data Task Force Report (2007)Using Real-World Data in Health Technology Assessment (HTA) Practice: A Comparative Study of Five HTA Agencies (2017)Real world evidence (RWE) – a disruptive innovation or the quiet evolution of medical evidence generation? (2018)Real world evidence: experience and lessons from China (2018)Git can facilitate greater reproducibility and increased transparency in science (2013)Ten Simple Rules for Taking Advantage of Git and GitHub (2016)Council for International Organizations of Medical Sciences (CIOMS) (2025)
this work references cited by second hop

References

  • 2016ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions20,225 cited
  • 2003A Checklist for Retrospective Database Studies—Report of the ISPOR Task Force on Retrospective Databases412 cited
  • 2017Policies for Use of Real-World Data in Health Technology Assessment (HTA): A Comparative Study of Six HTA Agencies206 cited
  • 2010Registration of observational studies: Is it time?152 cited
  • 2014Improving the Transparency of Prognosis Research: The Role of Reporting, Data Sharing, Registration, and Protocols152 cited
  • 2016The GRACE Checklist: A Validated Assessment Tool for High Quality Observational Studies of Comparative Effectiveness132 cited
  • 2010Comparative Effectiveness Research: Challenges for Medical Journals29 cited

Cited by

  • 2024The FAIRification of research in real‐world evidence: A practical introduction to reproducible analytic workflows using Git and R7 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work